FTC Staff Comment: FDA Should Reevaluate Its Current Regulatory Framework for Homeopathic Products

The staff of the Federal Trade Commission has recommended that the U.S. Food and Drug Administration reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s advertising substantiation doctrine in ways that could harm consumers and cause confusion for advertisers. In a comment submitted to the FDA, […]